Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

被引:1
|
作者
Karim, N. [1 ]
Pathrose, J. [2 ]
Fathallah, H. [1 ]
El Desouki, I. [1 ]
Perry, A. [1 ]
Starnes, S. [3 ]
Morris, J. [1 ]
机构
[1] Univ Cincinnati, Internal Med, Cincinnati, OH USA
[2] Univ Cincinnati, Mcmicken Coll Arts & Sci 1, Cincinnati, OH USA
[3] Univ Cincinnati, Surg, Cincinnati, OH USA
关键词
D O I
10.1016/j.jtho.2018.08.1184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-129
引用
收藏
页码:S714 / S715
页数:2
相关论文
共 50 条
  • [41] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] COST-EFFECTIVENESS OF NIVOLUMAB FOR THE TREATMENT OF ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) IN SAUDI ARABIA
    Alhammad, A.
    Lecca, Garrido S.
    VALUE IN HEALTH, 2016, 19 (07) : A741 - A741
  • [44] Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
    Gonzalez, P.
    Ortega-Joaquin, N.
    Provencio Pulla, M.
    Garrido, C.
    Echave, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Maintenance pemetrexed for non-squamous non-small cell lung cancer (NSCLC): 'real life' outcomes from a UK centre
    Lim, J.
    Neocleous, M.
    Coote, J.
    Woolf, D.
    Bayman, N.
    Lee, L.
    Sheikh, H.
    Blackhall, F.
    Califano, R.
    Summers, Y.
    LUNG CANCER, 2017, 103 : S30 - S31
  • [46] A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
    Panje, Cedric M.
    Dedes, Konstantin J.
    Matter-Walstra, Klazien
    Schwenkglenks, Matthias
    Gautschi, Oliver
    Siano, Marco
    Aebersold, Daniel M.
    Plasswilm, Ludwig
    Lupatsch, Judith E.
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 257 - 263
  • [47] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [48] A non-pathway-specific approach in EGFR and KRAS mutant or squamous cell histology non-small cell lung cancer (NSCLC)
    Ito, M.
    Codony-Servat, C.
    Codony-Servat, J.
    Attili, I.
    Berenguer, J.
    Bracht, J.
    Gil, N.
    Okada, M.
    Karachaliou, N.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S13 - S14
  • [49] The potential cost-effectiveness of first-line immunotherapy plus chemotherapy for advanced non-squamous non-small cell lung cancer (NSCLC).
    Roth, Joshua A.
    Trung Nguyen
    Goulart, Bernardo H. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    LUNG CANCER, 2019, 129 : 35 - 40